Abbott research business spin off steers clear of Pill Hill operations
A corporate shuffle at the global drug maker will not impact the company’s Mississauga diabetes and diagnostic tests division
Writer & Business Reporter
A corporate shuffle at the global drug maker will not impact the company’s Mississauga diabetes and diagnostic tests division
A Thursday ruling opens the door to generic or brand-name drug makers to develop and sell cheaper versions of the erectile dysfunction drug Viagra
Meadowvale’s “Pill Hill” is a cluster of most of the city’s biotechnology, biomedical and other life-science companies
Lack of government support, company consolidation and gridlock are major challenges preventing large growth of Mississauga’s biotechnology and biomedical sector